Skip to Main Content
Multiple Myeloma

A Prospective, Observational Study of Real-World Efficacy and Patient-Reported Quality of Life

What is the purpose of this trial?

To evaluate patient-reported health-related quality of life outcomes in subjects with RRMM treated with daratumumab-based regimens in a real life setting.

Contact Information

For more information about this study, including how to volunteer, contact Kylie Boyhen

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    10/10/2024
  • Study HIC
    #2000026739